Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2018-09-10 Regulatory Filings
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2018
Regulatory Filings Classification · 90% confidence The document text appears to be encoded or corrupted and does not contain any readable content or keywords related to specific financial filings. The metadata indicates the document length is 9731 characters, which is substantial, but the content is not interpretable as a financial report or announcement. There are no clear indications of report titles, fiscal periods, regulatory bodies, or financial data. Given the lack of meaningful content and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific types.
2018-09-10 English
Regulatory Filings 2018
Regulatory Filings
2018-09-10 English
FWP
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Titan Pharmaceuticals, Inc. It announces the award of a grant by the NIH/NIDA for development of a drug implant. The document includes a press release and details about the grant and company activities. There are no financial statements or detailed financial performance data presented. The document is primarily an announcement of a significant event (grant award) and related press release, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the event. The document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and current report filing that does not fit other specific categories like earnings release or capital update.
2018-09-10 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content includes an announcement of a grant award from NIH and a board member appointment to another company's board. There are no financial statements or detailed financial data presented. The document is relatively short (3830 characters) and includes a press release as an exhibit. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Earnings Release, or Management Reports. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-09-10 English
FREE WRITING PROSPECTUS
Investor Presentation Classification · 95% confidence The document is titled 'FREE WRITING PROSPECTUS' and contains detailed information about an offering, including use of proceeds, underwriters, leadership, company snapshot, product pipeline, regulatory status, and market context. It references a registration statement filed with the SEC but not yet effective, and includes disclaimers typical of offering materials. The content is a corporate presentation aimed at investors, focusing on financials, strategy, and market position related to a securities offering. It is not a full financial report, audit, earnings release, or regulatory filing. The document is a detailed investor presentation associated with a securities offering, consistent with the definition of Investor Presentation (IP).
2018-09-04 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes the standard SEC header for Form 8-K, the date of the report, company details, and specific items reported such as 'Other Events' and a press release attachment. The content describes the announcement of a pilot program collaboration, which is a typical use of Form 8-K to disclose significant events. The document length is 3204 characters, which is relatively short and consistent with an 8-K filing. There is no detailed financial data or comprehensive report content that would classify it as an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a report publication announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2018-09-04 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.